Cardiomyopathy Trial, Recruiting NCT06646601 Sponsor: Assistance Publique Hopitaux De Marseille Condition: Cardiomyopathy
Back to Cardiomyopathy

Cardiomyopathy Trial, Recruiting

NCT06646601
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are over 18 years old
  • You live within approximately 20 km of Gap, Laragne-Montéglin, Veynes, or Clermont-Ferrand in France
  • You have been personally invited to take part by staff at a medical facility involved in the trial
  • You have been diagnosed with one of the following long-term conditions: stroke, peripheral artery disease (blocked arteries in the legs), heart rhythm problems, heart valve disease, a heart condition present from birth, mild to moderate heart failure (early stages), severe high blood pressure, or chronic coronary disease (ongoing reduced blood flow to the heart)

Who may not be able to join:

  • You have been diagnosed with severe heart failure (stages III or IV, meaning significant symptoms during minimal activity or at rest)
  • You have a medical reason why physical activity or exercise is not safe for you
  • You currently live in a care home or similar institution
  • You are unable to walk more than 100 metres on your own
  • You have Alzheimer's disease or another diagnosed form of dementia
  • You have a cognitive (thinking or understanding) difficulty that makes it hard to understand instructions or information, even if not formally diagnosed (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +33491381245

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
9 April 2024
Est. completion
31 March 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Acceptance rate of intervention; Identification of the obstacles and facilitators for intervention

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov